Home - JDNPPA

Catching Up With Past and Present Beiersdorf Residents of Distinction

CLE Linked to ASCVD: Exploring the Implications for Heart Disease Screening

January 13, 2025

FDA Approves New Nonsteroidal Topical for AD: All About Tapinarof Cream, 1% (Vtama, Organon)

December 16, 2024

Tapinarof Cream 1% (Vtama, Organon) Approved in AD: Organon’s Phil Brown, MD, JD, Discusses the New Indication

December 16, 2024

U.S. FDA Approves Nemolizumab (Nemluvio, Galderma) for Patients with Moderate to Severe AD

December 14, 2024

Advertisement

Grand Rounds: Atopic Dermatitis

Raising the Bar in Atopic Dermatitis: Unpacking the practice-changing implications of the LEVEL UP study in AD

Let’s Talk About Acne

Prescribing Hope: Exploring What’s Possible with Topical JAK Inhibition in Vitiligo

Advertisement

Latest Issue

Latest Supplement

Advertisement

Digital Edition Archive